| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,308 | 10,010 | 8,586 | 11,751 | | Cost of Revenue | 3,715 | 3,961 | 3,871 | 4,862 | | | Gross Profit | 4,593 | 6,049 | 4,715 | 6,889 | | | Operating Expenses | | Research Development | 1,195 | 1,088 | 1,349 | 1,516 | | Selling General and Administrative | 4,184 | 4,538 | 4,158 | 4,041 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 172 | 165 | 157 | 158 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (958) | 258 | (949) | 1,174 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (158) | (143) | (290) | (511) | | Earnings Before Interest And Taxes | (1,116) | 115 | (1,239) | 663 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,116) | 115 | (1,239) | 663 | | Income Tax Expense | 154 | 242 | (474) | 3,620 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,270) | (127) | (765) | (2,957) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,270) | (127) | (765) | (2,957) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,270) | ($127) | ($765) | ($2,957) |
|
0.03% Nasdaq 
Income Statement
